Navigation Links
ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc.
Date:7/14/2014

EAGAN, Minn., July 14, 2014 /PRNewswire/ -- Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA.  The acquisition of MTL is the first step in the strategy of ATS to expand its microbiology and chemistry laboratory services platform to support the medical device and biopharmaceutical industries.  The combined companies will soon be known as Accuratus Lab Services, a name that personifies the quality and accuracy of testing results and scientific solutions that support the antimicrobial, consumer product, medical device, and biopharmaceutical industries.

"The acquisition of MicroTest by ATS has been a long time in the making and I could not be more pleased about the future of the two companies and how they will combine to create the market leader in providing microbiology and analytical chemistry testing services," said Dr. Steve Richter, CEO of MTL.  Dr. Tom Burnell, Executive Chairman of ATS added, "Like ATS, MicroTest has a strong reputation in the industries it serves, which is supported by long-standing client relationships. Leveraging the strengths of the two companies will only further enhance our ability to continuously exceed our client's expectations."  It is expected that administrative functions will be consolidated, but the company will continue to operate at its locations in Eagan, MN and Agawam, MA.

About ATS Labs:ATS Labs is the leading global provider of antimicrobial and biocide testing services; committed to improving public health and generating value for customers.  ATS Labs has been an expert partner to the developers, manufacturers, and users of antimicrobial products for over 20 years; providing a comprehensive range of microbiology, virology, and product chemistry services.  For more information on ATS Labs go to www.ATS-Labs.com.

About MicroTest Labs:MicroTest Labs is a leader in testing services for the medical device, pharmaceutical and biotechnology industries.  Founded in 1984, the company's expertise and flexible processes enhance product safety and security, speed time to market, and minimize supply chain disruption.  For more information on MicroTest Labs go to www.MicroTestLabs.com.

About Ampersand Capital Partners:Ampersand is a middle market private equity firm with a focus on growth equity investments in the Healthcare sector.  Over the past two decades, Ampersand has managed $1 billion in private equity partnerships.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams.  Additional information about Ampersand is available at www.AmpersandCapital.com.For More Information:Dr. Tom Burnell

ATS Labs, Inc.Executive Chairman 

1285 Corporate Center DriveEmail: tom.burnell@ats-labs.com 

Suite 110(402) 613-4184 

Eagan, MN 55121Logo - http://photos.prnewswire.com/prnh/20131206/CG29153LOGO


'/>"/>
SOURCE ATS Labs
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Endexx Enters Into Definitive Agreement to Acquire Dispense Labs, LLC
2. PharmaRoth Labs, Inc. Announces Trading Symbol Change
3. PharmaRoth Labs, Inc. Files New Dietary Ingredient Notification with the US Food and Drug Administration (FDA)
4. Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics
7. Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc.
8. ISSI Announces Fiscal 2014 Third Quarter Conference Call
9. CVS Caremark Corporation Announces Quarterly Dividend
10. Sono-Tek Announces Third Quarter Results
11. Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Summary Breast cancer, a malignant neoplasm, is ... cancer in women worldwide, accounting for 16% of all ... of women diagnosed with breast cancer has increased over ... has declined due to earlier diagnosis and better treatment ... the past four decades, especially with increasing usage of ...
(Date:2/4/2016)... MOUNTAIN VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... supply management solutions to healthcare systems, today announced results ... 2015.  --> --> ... was $130.3 million, up $5.1 million or 4.1% from ... or 7.2% from the fourth quarter of 2014. Revenue ...
(Date:2/4/2016)... , Feb. 4, 2016 In response to the ... FDA,s Deputy Commissioner for Medical Products and Tobacco, along with ... reassess the agency,s approach to opioid medications. The plan will ... providing patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at ... of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, and ... , For Valentine’s Day, not only are long-stem roses available, but also other flower ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... ... February 05, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... again host, Swirl, A Wine Tasting Event at the La Gorce Country Club ...
(Date:2/5/2016)... Dallas, Texas (PRWEB) , ... February 05, 2016 , ... ... to allow users to search for and donate to Give To Cure’s campaign ... is an app that lets users make and share payments through a smart device. ...
(Date:2/5/2016)... MA (PRWEB) , ... February 05, 2016 , ... ... in tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, ... option with unmatched results. , Developed by Cynosure, the PicoSure has been approved by ...
Breaking Medicine News(10 mins):